Secondary Logo

Institutional members access full text with Ovid®

Cognitive Impairment Level and Elderly Hip Fracture

Implications in Rehabilitation Nursing

Jiménez Mola, Sonia, PhD1; Calvo-Lobo, César, PhD2; Idoate Gil, Javier, PhD1; Seco Calvo, Jesús, PhD3,4

doi: 10.1097/rnj.0000000000000159
Current Issues: PDF Only
Buy
PAP

Purpose: The aim of the study was to determine the cognitive impairment level influence in descriptive characteristics, comorbidities, complications, and pharmacological features of older adults with hip fracture.

Design: Cross-sectional study.

Method: Five hundred fifty-seven older adults with hip fracture were recruited and divided into cognitive impairment levels (severe/moderate, mild, no impairment). Descriptive characteristics, comorbidities, complications, and pharmacological data were collected.

Findings: Significant differences (p < .05, R2 = .012–.475) between cognitive impairment levels were shown. Shorter presurgery hospital length of stay and lower depression and Parkinson comorbidities; delirium complication; and antidepressants, antiparkinsonians, and neuroleptics use were shown for the no-impairment group. With regard to the cognitive impairment groups, lower presence of cardiopathy and hypertension; higher presence of dementia; antihypertensives, antiplatelets, and antidementia medication; infection/respiratory insufficiency complications; and lower constipation complications were shown.

Conclusion: Cognitive impairment levels may determine the characteristics, comorbidities, pharmacology, and complications of older adults with hip fracture.

Clinical Relevance: Cognitive impairment level may impact rehabilitation nursing practice, education, and care coordination.

1 Ortogeiatric Unit, Complejo Asistencial Universitario de León (CAULE), León, Spain.

2 Nursing and Physical Therapy Department, Institute of Biomedicine (IBIOMED), Universidad de León, León, Spain.

3 Institute of Biomedicine (IBIOMED), University of León, León, Spain.

4 University of the Basque Country (UPV/EHU), Leioa, Spain.

Correspondence: César Calvo-Lobo, PhD, Nursing and Physical Therapy Department, Institute of Biomedicine (IBIOMED), Faculty of Health Sciences, University of León, Av. Astorga, s/n, 24401 Ponferrada, León, Spain. E-mail: ccall@unileon.es

Ethical Considerations:

The study was approved by the Clinical Research Ethics Committee of the León University (Spain; Code ÉTICA-ULE-004-2015). Informed written consent form was obtained from all participants before their inclusion in the research study. Furthermore, the Helsinki Declaration, Protection Data Organic Law (15/1999), and ethical standards in human experimentation were respected.

© 2019 Association of Rehabilitation Nurses.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website